Suchergebnisse - "Lee, Aaron Y"

PubPharm (13)

1

Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion : intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections

enthalten in: The British journal of ophthalmology | 2021

von Gale, R. | Gill, C. | Pikoula, M. | +7

2

Artificial intelligence-based predictions in neovascular age-related macular degeneration

enthalten in: Current opinion in ophthalmology | 2021

von Ferrara, D. | Newton, E. | Lee, A.

3

Evolving Treatment Patterns and Outcomes of Neovascular Age-Related Macular Degeneration Over a Decade

enthalten in: Ophthalmology. Retina | 2021

von Schwartz, R. | Warwick, A. | Olvera-Barrios, A. | +36

4

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser

enthalten in: The British journal of ophthalmology | 2021

von Gale, R. | Pikoula, M. | Lee, A. | +32

5

Moorfields AMD database report 2 : fellow eye involvement with neovascular age-related macular degeneration

enthalten in: The British journal of ophthalmology | 2020

von Fasler, K. | Fu, D. | Moraes, G. | +12

6

One- and two-year visual outcomes from the Moorfields age-related macular degeneration database : a retrospective cohort study and an open science resource

enthalten in: BMJ open | 2019

von Fasler, K. | Moraes, G. | Wagner, S. | +11

7

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

enthalten in: Progress in retinal and eye research | 2018

von Mehta, H. | Tufail, A. | Daien, V. | +5

8

VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED

enthalten in: Retina (Philadelphia, Pa.) | 2018

von Lee, C. | Kim, A. | Baughman, D. | +12

9

UK AMD/DR EMR REPORT IX : comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

enthalten in: The British journal of ophthalmology | 2017

von Lee, A. | Lee, C. | Egan, C. | +11

10

UK Neovascular Age-Related Macular Degeneration Database. Report 6 : time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections

enthalten in: The British journal of ophthalmology | 2016

von Madhusudhana, K. | Lee, A. | Keane, P. | +25